Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.

about

Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q36128358

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Definitive Upfront Stereotacti ...... ed Non-Small Cell Lung Cancer.

@ast

Definitive Upfront Stereotacti ...... ed Non-Small Cell Lung Cancer.

@en

type

Item

label

Definitive Upfront Stereotacti ...... ed Non-Small Cell Lung Cancer.

@ast

Definitive Upfront Stereotacti ...... ed Non-Small Cell Lung Cancer.

@en

prefLabel

Definitive Upfront Stereotacti ...... ed Non-Small Cell Lung Cancer.

@ast

Definitive Upfront Stereotacti ...... ed Non-Small Cell Lung Cancer.

@en

P1476

Definitive Upfront Stereotacti ...... ed Non-Small Cell Lung Cancer.

@en

P2093

Alexander Chi

http://www.w3.org/2001/XMLSchema#string

Manish Monga

http://www.w3.org/2001/XMLSchema#string

Mohammed Almubarak

http://www.w3.org/2001/XMLSchema#string

Scot C Remick

http://www.w3.org/2001/XMLSchema#string

Sijin Wen

http://www.w3.org/2001/XMLSchema#string

William Tse

http://www.w3.org/2001/XMLSchema#string

Xiaoqing He

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.

Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience

Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer.

Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer.

Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.

P304

e0162453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0162453

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yon Rojanasakul

P577

2016-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27611833

http://www.w3.org/2001/XMLSchema#string

P932

5017732

http://www.w3.org/2001/XMLSchema#string